IVF INVO Fertility, Inc. Common Stock

$IVF I check everything you know.. and give it to you for free.... and it's a very hard work ..but we all can make money together..

$IVF I see some friends trading, holding, and commenting on stocks that, in my opinion, just don’t look good ..You’ll also notice that I never post negatively on other stocks or attack someone else’s trade. I know real people have real money invested, and I don’t want to play with anyone’s emotions. I’d rather focus on the stocks I believe offer us the better opportunities. Wish those people come and join us too..❤️📈

$IVF In with a starter position, Shares outstanding: ~ 2.5M Public Float: ~2.5M - (Small float) Q2 revenue growth: 🟢 Operating-loss improvement: 🟢🟢 Clinic EBITDA: 🟢 Headline Q2 profitability: 🟢 PRP catalyst: 🟢 Float: 🔥🔥 ~2.5M Cash situation: 🟢 Improved $7.95 warrants: 🟢 At lower prices 10%–50% swing possibility IMO

$IVF Loaw float. High squeeze potential. * $1.25 → reasonable first breakout target * $1.50 → strong momentum * $2.00 → very bullish * $3.00+ → possible squeeze Early bird gets the worm.

$IVF People don`t get that MMs n Shorts want you to think this will never be anything but a pile of dog shit,n a pump n dump stock. They don`t want you to believe it could be a turnaround story,mainly because they're maxed on their short positions here. It`s all head games to trick you into selling,instead buying n holding for $20-$30 a share. That`s coming to this ticker n more,because their clinics are bringing in the dough n it`s only going to get bigger n make them cash positive on earnings,which then commands a forward multiple of 8 to 10 times earnings. 35-45 a share then becomes the target. I`ll still be here to take my bows after I`m proven rt,,,will you be an owner n cash out too?

$IVF The MMs n Shorts goal today is to try n break below 1.10,like they did with their paint job last night after hours. Every share we buy to support this level and stop them,makes the borrowing rate go up even further,deepening their graves, and supercharging the upcoming squeeze.

$IVF 1. H.C. Wainwright conference — Sept. 14–16 * INVO announced today, Aug. 28, that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference. * Its presentation becomes available Sept. 11 at 7:00 AM ET. * This can create a near-term trading catalyst if management provides stronger growth guidance, clinic expansion plans, or financing updates. 2. Q2 results showed continued revenue growth * INVO’s latest quarterly results were reported in August and showed continued expansion of its fertility-clinic platform. * The company previously reported 23% Q1 revenue growth, reaching about $2.0M. * Continued double-digit growth in Q2/Q3 would be a strong fundamental catalyst

$IVF Guys ....this time I sold it at 1.27 ,automatic sell order, I'm on vacation, but I'm tired ...good luck guys 💪💪

$IVF has the ingredients for a low float huge momentum squeeze 🚀 TINY float, this could move fast. 🔥

$IVF primed and on the scanners, need that 20mil volume infusion to really make it run away 🏃‍♂️

$IVF Those are gonna be bags of money coming into IVF`s clinics once the insurance checks start rolling in.

$IVF small starter...imo i dont like to see bids waiting on a lower price...not hating i totally get it

$IVF INVO Fertility took full ownership of its Alabama clinic and resolved its Nasdaq compliance matter.

$IVF when do people willl learn that mister nga tammy is telling you to buy stock after he bought so he can make a quick 20%

$IVF There actually are several real catalysts in IVF: Clinic expansion: INVO is building a network of fertility clinics rather than depending entirely on its INVOcell technology. Acquisitions: The company announced the acquisition of Family Beginnings, a Midwest fertility clinic with approximately $1.2M of annual revenue and $0.2M of net income. S Stocktwits Alabama clinic: INVO took full ownership of its Alabama clinic, which Stocktwits identified as one of the catalysts behind a previous sharp move. S Stocktwits Fertility-market theme: IVF treatment affordability and access remain popular investment themes, which makes the company easy for retail traders to understand.

$IVF The clinic platform is profitable All Series C-2 preferred converted or retired and warrant liabilities eliminated; $7.1M of net proceeds received from warrant exercises in H1 2026. Materially stronger balance sheet Cash of $3.7M vs. $2.1M at year-end; total liabilities down to $9.3M from $13.0M; stockholders’ equity up to $16.5M from $7.2M. NAYA distraction fully behind us Divesting NAYA made INVO a pure-play fertility company. Capital and management bandwidth once split with a clinical-stage biotech now go entirely to operating and acquiring clinics. Financial flexibility in place $15M equity purchase facility with Alumni Capital became available August 4, 2026 — usable at the Company’s sole discretion. Clinic-Level Adjusted EBITDA of $333K in Q2 2026, up from $164K in Q1 2026, and $951K for full year 2025, before corporate and public company costs. Revenue growing on both engines Q2 revenue up 17% on the first full quarter of Family Beginnings

$IVF apologies for the stupid question but what is the next catalyst that people are waiting on? This one feels like a loaded gun but I’m unsure what type of ammunition will be loaded

NCRA could be the biggest runner in a while 1m float Cash on hand 8 catalysts!!!!! Breakout chart to $5 then double digits 494% CTB , AI infrastructure and MEMORY with ties to mega caps $IVF $VEEE $SLE $MASK.X 🦍🦍🦍🦍🦍🦍🦍

$IVF sold about 2.1M shares to Alumni Capital for $3.6M under its Any Market Purchase Agreement.

$IVF nah, out and off WL for now. Yesterday was just a one time off pump, looks like it. Will ride the next one again.